Jaren Madden
Investor Relations Contact chez SCHRÖDINGER, INC.
Postes actifs de Jaren Madden
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SCHRÖDINGER, INC. | Investor Relations Contact | 01/11/2020 | - |
| Public Communications Contact | 01/11/2020 | - |
Historique de carrière de Jaren Madden
Anciens postes connus de Jaren Madden
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Shire Plc /Old/
 Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Directeur Technique/Scientifique/R&D | 01/11/2017 | 01/07/2018 |
| INFINITY PHARMACEUTICALS, INC. | Investor Relations Contact | 01/01/2010 | 01/01/2017 |
| Public Communications Contact | 01/01/2010 | 01/01/2017 | |
| GAMIDA CELL LTD. | Investor Relations Contact | 01/07/2018 | - |
| Public Communications Contact | 01/07/2018 | - |
Formation de Jaren Madden
| University of Connecticut | Graduate Degree |
| Boston University | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 6 |
| Royaume-Uni | 2 |
Opérationnelle
| Investor Relations Contact | 3 |
| Public Communications Contact | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| GAMIDA CELL LTD. | Health Technology |
| SCHRÖDINGER, INC. | Technology Services |
| Entreprise privées | 1 |
|---|---|
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Commercial Services |
- Bourse
- Insiders
- Jaren Madden
- Expérience